Robert Lacaze

Robert LaCaze is Chief Executive Officer at Mnemo. An accomplished and recognized leader with a focus on driving innovation and value for patients, Robert brings over 30 years of experience in the biopharmaceutical industry with a specialty in Oncology. Previously as the Executive Vice President and Head of the Oncology Strategic Business Unit at Bayer, Robert oversaw the Oncology franchise of Bayer AG globally. Before joining Bayer in 2015 as Senior Vice President, Head of Oncology, Robert was the Senior Vice President, Global Oncology at Bristol-Myers Squibb and co-led the Oncology Disease Strategy team with direct responsibility to set and implement the vision, and strategy for the Oncology franchise at Bristol-Myers Squibb, including Immuno-Oncology (I-O). Robert currently serves on the Louisiana Tech College of Business Administration Advisory Board and is a member of AACR and BioCentury. Robert received a Bachelor of Science in business marketing from Louisiana Tech University.